Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs Q✓SelectedUSD · QGSK vs Q performance historyLatest closeAs of-0.08%11/16
Stock and ETF performance explorer

GSK vs Q

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+20.2%
Q return
+63.5%
Excess return
-43.2%
Maximum drawdown
-22.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioQExcessAlpha
1D-0.1%-2.9%+2.8%-0.2%
7D-1.3%-8.1%+6.8%-1.7%
30D+2.7%-0.4%+3.1%+2.8%
3M+2.7%-19.2%+21.9%+2.4%
6M+3.3%-26.8%+30.1%+3.0%
YTD+6.5%+41.1%-34.6%+3.1%
1Y+10.7%+38.1%-27.4%+7.4%
All+20.2%+63.5%-43.2%+18.2%

Cumulative growth

Daily Returns

Daily percentage return beside Q.

Daily Out/Under-Performance

Portfolio return minus Q return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × Q return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded Q wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling